Gene medicine for treating arthritis

Through the combination of NPY gene therapy and rAAV vector, frequent administration and side effects in the treatment of gouty arthritis and rheumatoid arthritis are solved, and the drug half-life is prolonged and adverse reactions are reduced, providing a cost-effective treatment plan.

CN119300855APending Publication Date: 2025-01-10STARRYGENE THERAPEUTICS CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202480002147.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2023-08-07
Filing Date
2024-08-05
Publication Date
2025-01-10

Smart Images

  • Figure BSB0000209672490000111
    Figure BSB0000209672490000111
  • Figure BSB0000209672490000121
    Figure BSB0000209672490000121
  • Figure BSB0000209672490000131
    Figure BSB0000209672490000131
Patent Text Reader

Abstract

The invention discloses a gene medicine for treating arthritis. The invention discloses a gene therapy method based on neuropeptide-Y (NPY), a composition for treating gouty arthritis or rheumatoid arthritis by using rAAV as a carrier and application.
Need to check novelty before this filing date? Find Prior Art